Literature DB >> 1655704

Transposon mutagenesis in Proteus mirabilis.

R Belas1, D Erskine, D Flaherty.   

Abstract

A technique of transposon mutagenesis involving the use of Tn5 on a suicide plasmid was developed for Proteus mirabilis. Analysis of the resulting exconjugants indicated that Tn5 transposed in P. mirabilis at a frequency of ca. 4.5 x 10(-6) per recipient cell. The resulting mutants were stable and retained the transposon-encoded antibiotic resistance when incubated for several generations under nonselective conditions. The frequency of auxotrophic mutants in the population, as well as DNA-DNA hybridizaiton to transposon sequences, confirmed that the insertion of the transposon was random and the Proteus chromosome did not contain significant insertional hot spots of transposition. Approximately 35% of the mutants analyzed possessed plasmid-acquired ampicillin resistance, although no extrachromosomal plasmid DNA was found. In these mutants, insertion of the Tn5 element and a part or all of the plasmid had occurred. Application of this technique to the study of swarmer cell differentiation in P. mirabilis is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655704      PMCID: PMC208382          DOI: 10.1128/jb.173.19.6289-6293.1991

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  11 in total

1.  Mini-Tn5 transposon derivatives for insertion mutagenesis, promoter probing, and chromosomal insertion of cloned DNA in gram-negative eubacteria.

Authors:  V de Lorenzo; M Herrero; U Jakubzik; K N Timmis
Journal:  J Bacteriol       Date:  1990-11       Impact factor: 3.490

Review 2.  Nature of the swarming phenomenon in Proteus.

Authors:  F D Williams; R H Schwarzhoff
Journal:  Annu Rev Microbiol       Date:  1978       Impact factor: 15.500

3.  A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR.

Authors:  V L Miller; J J Mekalanos
Journal:  J Bacteriol       Date:  1988-06       Impact factor: 3.490

4.  In vivo DNA cloning and adjacent gene fusing with a mini-Mu-lac bacteriophage containing a plasmid replicon.

Authors:  E A Groisman; B A Castilho; M J Casadaban
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

5.  Trans-complementation-dependent replication of a low molecular weight origin fragment from plasmid R6K.

Authors:  R Kolter; M Inuzuka; D R Helinski
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

6.  Transposon mutagenesis of marine Vibrio spp.

Authors:  R Belas; A Mileham; M Simon; M Silverman
Journal:  J Bacteriol       Date:  1984-06       Impact factor: 3.490

7.  Cloning of genes from members of the family Enterobacteriaceae with mini-Mu bacteriophage containing plasmid replicons.

Authors:  E A Groisman; M J Casadaban
Journal:  J Bacteriol       Date:  1987-02       Impact factor: 3.490

8.  New Tn10 derivatives for transposon mutagenesis and for construction of lacZ operon fusions by transposition.

Authors:  J C Way; M A Davis; D Morisato; D E Roberts; N Kleckner
Journal:  Gene       Date:  1984-12       Impact factor: 3.688

9.  Proteus mirabilis mutants defective in swarmer cell differentiation and multicellular behavior.

Authors:  R Belas; D Erskine; D Flaherty
Journal:  J Bacteriol       Date:  1991-10       Impact factor: 3.490

10.  Broad host range DNA cloning system for gram-negative bacteria: construction of a gene bank of Rhizobium meliloti.

Authors:  G Ditta; S Stanfield; D Corbin; D R Helinski
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  66 in total

1.  Proteus mirabilis glutathione S-transferase B1-1 is involved in protective mechanisms against oxidative and chemical stresses.

Authors:  Nerino Allocati; Bartolo Favaloro; Michele Masulli; Mikhail F Alexeyev; Carmine Di Ilio
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

2.  Perturbation of FliL interferes with Proteus mirabilis swarmer cell gene expression and differentiation.

Authors:  Kathleen Cusick; Yi-Ying Lee; Brian Youchak; Robert Belas
Journal:  J Bacteriol       Date:  2011-11-11       Impact factor: 3.490

3.  Periodic phenomena in Proteus mirabilis swarm colony development.

Authors:  O Rauprich; M Matsushita; C J Weijer; F Siegert; S E Esipov; J A Shapiro
Journal:  J Bacteriol       Date:  1996-11       Impact factor: 3.490

4.  Molecular analysis of a metalloprotease from Proteus mirabilis.

Authors:  C Wassif; D Cheek; R Belas
Journal:  J Bacteriol       Date:  1995-10       Impact factor: 3.490

5.  Expression of multiple flagellin-encoding genes of Proteus mirabilis.

Authors:  R Belas
Journal:  J Bacteriol       Date:  1994-12       Impact factor: 3.490

6.  Activity of Proteus mirabilis FliL is viscosity dependent and requires extragenic DNA.

Authors:  Yi-Ying Lee; Julius Patellis; Robert Belas
Journal:  J Bacteriol       Date:  2012-12-07       Impact factor: 3.490

7.  Characterization of Proteus mirabilis precocious swarming mutants: identification of rsbA, encoding a regulator of swarming behavior.

Authors:  R Belas; R Schneider; M Melch
Journal:  J Bacteriol       Date:  1998-12       Impact factor: 3.490

8.  Characterization of 17 chaperone-usher fimbriae encoded by Proteus mirabilis reveals strong conservation.

Authors:  Lisa Kuan; Jessica N Schaffer; Christos D Zouzias; Melanie M Pearson
Journal:  J Med Microbiol       Date:  2014-05-08       Impact factor: 2.472

9.  Proteus mirabilis ZapA metalloprotease degrades a broad spectrum of substrates, including antimicrobial peptides.

Authors:  Robert Belas; Jim Manos; Rooge Suvanasuthi
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

Review 10.  Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis.

Authors:  S M Jacobsen; D J Stickler; H L T Mobley; M E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.